Home
Advanced Search
Help
Update History
Statistics
Downloads
The Barton Group

Predicted interactions involving protein WAS, IMD2: Wiskott-Aldrich syndrome protein (IPI00001545) that score above 1.0

Click on the protein name for more information about the protein.

The Score column is the predicted score of interaction between the two proteins

Click on the Evidence link to view a breakdown of the information about the predicted interaction.

Key
Module ScoreDatabases
Where interaction is observed in another database a link is provided:

Protein 1 (?)Protein 2 (?) Name of Protein 2 Module Scores (?) Scores (?) Evidence (?) Database (?)
WAS WASPIP N/A 5.98E4 Evidence
WAS VAV1 VAV1, VAV: Proto-oncogene vav 3.10E4 Evidence
WAS ACTG1 ACTB: Actin, cytoplasmic 1 2.80E4 Evidence
WAS ACTG1 ACTR2, ARP2: Actin-related protein 2 1.59E4 Evidence
WAS FGR FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR 1.20E4 Evidence O
WAS CD2AP CD2AP: CD2-associated protein 1.01E4 Evidence
WAS HCK N/A 9.29E3 Evidence O
WAS WASL WASL: Neural Wiskott-Aldrich syndrome protein 6.70E3 Evidence
WAS NCK1 NCK1, NCK: Cytoplasmic protein NCK1 5.62E3 Evidence O
WAS SH3KBP1 SH3KBP1, CIN85: SH3 domain-containing kinase-binding protein 1 4.68E3 Evidence
WAS CRKL CRKL: Crk-like protein 3.35E3 Evidence O
WAS CFL1 CFL1, CFL: Cofilin-1 1.12E3 Evidence
WAS GRAP GRAP: GRB2-related adapter protein 1.01E3 Evidence
WAS GRB2 GRB2, ASH: Growth factor receptor-bound protein 2 717.0 Evidence
WAS FRK FRK, PTK5, RAK: Tyrosine-protein kinase FRK 702.0 Evidence
WAS HCLS1 HCLS1, HS1: Hematopoietic lineage cell-specific protein 678.0 Evidence
WAS ACTR3 ACTR3, ARP3: Actin-related protein 3 373.0 Evidence
WAS CSK CSK: Tyrosine-protein kinase CSK 226.0 Evidence
WAS TYK2 TYK2: Non-receptor tyrosine-protein kinase TYK2 194.0 Evidence
WAS RAP1B RAP1B, OK/SW-cl.11: Ras-related protein Rap-1b precursor 194.0 Evidence
WAS LYN LYN: Tyrosine-protein kinase Lyn 194.0 Evidence
WAS ACTC ACTC1, ACTC: Actin, alpha cardiac muscle 1 191.0 Evidence O
WAS JAK2 JAK2: Tyrosine-protein kinase JAK2 174.0 Evidence
WAS SH3BP2 SH3BP2: Uncharacterized protein SH3BP2 165.0 Evidence
WAS RPS6KA1 RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 148.0 Evidence
WAS DOCK2 DOCK2, KIAA0209: Dedicator of cytokinesis protein 2 148.0 Evidence
WAS CRK N/A 146.0 Evidence
WAS SYK SYK: Tyrosine-protein kinase SYK 105.0 Evidence
WAS MSN MSN: Moesin 98.10 Evidence
WAS STAT5A STAT5A, STAT5: Signal transducer and activator of transcription 5A 85.20 Evidence
WAS LCP2 LCP2: Lymphocyte cytosolic protein 2 77.90 Evidence O
WAS PIK3CG PIK3CG: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma i 69.40 Evidence
WAS JAK1 69.40 Evidence
WAS RAF1 RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase 69.40 Evidence
WAS ACTA1 ACTA1, ACTA: Actin, alpha skeletal muscle 68.60 Evidence
WAS SCAP2 SKAP2, PRAP, RA70, SAPS, SCAP2, SKAP55R: Src kinase-associated phosphoprotein 2 67.20 Evidence
WAS ZAP70 ZAP70: Uncharacterized protein ZAP70 62.90 Evidence
WAS KHDRBS1 KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate 59.00 Evidence
WAS CSF1R CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor 56.20 Evidence
WAS BTK BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK 55.10 Evidence O
WAS MAP4K1 MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 49.60 Evidence
WAS ESX1 ESX1L, ESX1R: Extraembryonic, spermatogenesis, homeobox 1-like protein 44.90 Evidence
WAS TBK1 TBK1, NAK: Serine/threonine-protein kinase TBK1 44.40 Evidence
WAS PRKAA1 N/A 43.60 Evidence
WAS ADRBK1 ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 42.00 Evidence
WAS PRKD2 PRKD2, PKD2, HSPC187: Serine/threonine-protein kinase D2 42.00 Evidence
WAS LCP1 LCP1, PLS2: Plastin-2 37.80 Evidence
WAS MAP2K5 N/A 37.80 Evidence
WAS BLNK BLNK, BASH, SLP65: B-cell linker protein 36.60 Evidence
WAS ACTB ACTG1, ACTB, ACTG: Actin, cytoplasmic 2 35.60 Evidence
WAS FNBP1 N/A 35.10 Evidence
WAS OSTF1 N/A 35.00 Evidence
WAS STK38L STK38L, KIAA0965, NDR2: Serine/threonine-protein kinase 38-like 33.90 Evidence
WAS RPS6KB1 N/A 33.90 Evidence
WAS RGS2 RGS2, G0S8: Regulator of G-protein signaling 2 32.90 Evidence
WAS PKN2 PKN2, PRK2, PRKCL2: Serine/threonine-protein kinase N2 32.80 Evidence
WAS DOK1 DOK1: Docking protein 1 32.30 Evidence
WAS MYH9 MYH9: Myosin-9 31.40 Evidence
WAS PRKCQ PRKCQ, PRKCT: Protein kinase C theta type 31.20 Evidence
WAS CBLB CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B 29.30 Evidence
WAS YWHAB YWHAB: 14-3-3 protein beta/alpha 28.80 Evidence
WAS LCK LCK: Proto-oncogene tyrosine-protein kinase LCK 27.90 Evidence
WAS RASA3 RASA3: Ras GTPase-activating protein 3 26.80 Evidence
WAS SOS1 SOS1: Son of sevenless homolog 1 25.10 Evidence
WAS CD44 N/A 23.00 Evidence
WAS SRC SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src 22.70 Evidence
WAS STAT5B STAT5B: Signal transducer and activator of transcription 5B 22.30 Evidence
WAS PTPN12 PTPN12: Tyrosine-protein phosphatase non-receptor type 12 21.20 Evidence O
WAS EEF2K EEF2K: Elongation factor 2 kinase 20.50 Evidence
WAS TXK TXK, PTK4: Tyrosine-protein kinase TXK 20.50 Evidence
WAS PIK3CB PIK3CB, PIK3C1: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit 20.40 Evidence
WAS CSNK1E CSNK1E: Casein kinase I isoform epsilon 20.40 Evidence
WAS APS SH2B2, APS: SH2B adapter protein 2 20.40 Evidence
WAS LNK SH2B3, LNK: SH2B adapter protein 3 19.70 Evidence
WAS ABL2 ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 19.70 Evidence
WAS ABI1 ABI1, SSH3BP1: Abl interactor 1 19.70 Evidence
WAS AMPH AMPH, AMPH1: Amphiphysin 19.70 Evidence
WAS MAPK15 N/A 19.70 Evidence
WAS MINK1 MAP4K6, MINK1, MINK: Misshapen-like kinase 1 19.70 Evidence
WAS HLA-A HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor 18.80 Evidence
WAS PCBP1 PCBP1: Poly(rC)-binding protein 1 17.90 Evidence
WAS CDC2L5 CDC2L5, CDC2L, CHED, KIAA1791: Cell division cycle 2-like protein kinase 5 17.60 Evidence
WAS NEDD9 NEDD9, CASL: Enhancer of filamentation 1 17.60 Evidence
WAS STAT3 17.60 Evidence
WAS ITK ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK 17.60 Evidence O
WAS RASA1 RASA1, RASA: Ras GTPase-activating protein 1 17.60 Evidence
WAS CASP8 N/A 17.20 Evidence
WAS ABL1 ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 17.10 Evidence
WAS ELMO1 N/A 17.10 Evidence
WAS JUNB JUNB: Transcription factor jun-B 16.80 Evidence
WAS KIT KIT: Mast/stem cell growth factor receptor precursor 16.60 Evidence
WAS MICAL-L1 MICALL1, KIAA1668, MIRAB13: MICAL-like protein 1 16.20 Evidence
WAS CTTN CTTN, EMS1: Src substrate cortactin 16.00 Evidence
WAS CMTM6 CMTM6, CKLFSF6: CKLF-like MARVEL transmembrane domain-containing protein 6 15.60 Evidence
WAS PSKH1 PSKH1: Serine/threonine-protein kinase H1 15.50 Evidence
WAS HNRPK N/A 15.40 Evidence
WAS PTPN6 PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 15.00 Evidence
WAS FLT1 FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor 14.90 Evidence
WAS PDGFRA PDGFRA: Alpha-type platelet-derived growth factor receptor precursor 14.90 Evidence
WAS PDGFRB PDGFRB: Beta-type platelet-derived growth factor receptor precursor 14.90 Evidence
WAS CSF2RB CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor 14.70 Evidence
WAS CSNK1G2 CSNK1G2: Casein kinase I isoform gamma-2 14.70 Evidence
WAS ATR ATR, FRP1: Serine/threonine-protein kinase ATR 14.40 Evidence
WAS IRS2 IRS2: Insulin receptor substrate 2 14.10 Evidence
WAS GSK3A GSK3A: Glycogen synthase kinase-3 alpha 13.50 Evidence
WAS PTK2B PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta 13.40 Evidence
WAS LATS1 LATS1, WARTS: Serine/threonine-protein kinase LATS1 13.40 Evidence
WAS PHKG1 PHKG1, PHKG: Phosphorylase b kinase gamma catalytic chain, skeletal muscle isofo 13.40 Evidence
WAS CDC2 CDC2: Cell division control protein 2 homolog 13.40 Evidence
WAS FLT3 FLT3, STK1: FL cytokine receptor precursor 13.40 Evidence
WAS ALOX5 ALOX5, LOG5: Arachidonate 5-lipoxygenase 13.10 Evidence
WAS ADAM15 ADAM15, MDC15: ADAM 15 precursor 13.00 Evidence
WAS IL2RB IL2RB: Interleukin-2 receptor subunit beta precursor 12.60 Evidence
WAS GRAP2 GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 12.60 Evidence
WAS NCK2 NCK2: Cytoplasmic protein NCK2 12.60 Evidence
WAS CDC7 CDC7, CDC7L1: Cell division cycle 7-related protein kinase 12.40 Evidence
WAS MYO1F MYO1F: Myosin-If 12.10 Evidence
WAS PIK3R2 PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta 11.80 Evidence
WAS PRKCE PRKCE, PKCE: Protein kinase C epsilon type 11.80 Evidence
WAS EGFR EGFR, ERBB1: Epidermal growth factor receptor precursor 11.60 Evidence
WAS PRKCA PRKCA, PKCA, PRKACA: Protein kinase C alpha type 11.60 Evidence
WAS SNCA SNCA, NACP, PARK1: Alpha-synuclein 11.50 Evidence
WAS CD4 CD4: T-cell surface glycoprotein CD4 precursor 11.20 Evidence
WAS RP2 RP2: Protein XRP2 10.80 Evidence
WAS RAPGEF6 RAPGEF6, PDZGEF2: Rap guanine nucleotide exchange factor 6 10.60 Evidence
WAS PAK4 PAK4, KIAA1142: Serine/threonine-protein kinase PAK 4 10.40 Evidence
WAS EPS15 EPS15, AF1P: Epidermal growth factor receptor substrate 15 10.30 Evidence
WAS IKBKG IKBKG, FIP3, NEMO: NF-kappa-B essential modulator 10.20 Evidence
WAS CBL CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL 10.10 Evidence
WAS CDK5 CDK5: Cell division protein kinase 5 10.00 Evidence
WAS WEE1 WEE1: Wee1-like protein kinase 10.00 Evidence
WAS MAPK12 MAPK12, ERK6, SAPK3: Mitogen-activated protein kinase 12 10.00 Evidence
WAS SH3BP1 SH3BP1: SH3 domain-binding protein 1 9.93 Evidence
WAS FGFR1 FGFR1, FGFBR, FLG, FLT2: Basic fibroblast growth factor receptor 1 precursor 9.92 Evidence
WAS FGFR3 FGFR3, JTK4: Fibroblast growth factor receptor 3 precursor 9.92 Evidence
WAS AXL AXL, UFO: Tyrosine-protein kinase receptor UFO precursor 9.92 Evidence
WAS BMX N/A 9.89 Evidence
WAS HD HD, IT15: Huntingtin 9.76 Evidence
WAS QARS QARS: Glutaminyl-tRNA synthetase 9.32 Evidence
WAS MOS MOS: Proto-oncogene serine/threonine-protein kinase mos 9.0 Evidence
WAS PRKCZ PRKCZ, PKC2: Protein kinase C zeta type 9.0 Evidence
WAS ARHGEF7 N/A 8.92 Evidence
WAS PARD6A PARD6A, PAR6A: Partitioning defective 6 homolog alpha 8.92 Evidence
WAS INSR INSR: Insulin receptor precursor 8.90 Evidence
WAS EPHA7 EPHA7, EHK3, HEK11: Ephrin type-A receptor 7 precursor 8.90 Evidence
WAS ATP2A2 ATP2A2, ATP2B: Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 8.89 Evidence
WAS ERBB3 ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor 8.89 Evidence
WAS RET RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor 8.89 Evidence
WAS EPHA8 EPHA8, EEK, KIAA1459: Ephrin type-A receptor 8 precursor 8.89 Evidence
WAS STAT1 STAT1: Signal transducer and activator of transcription 1-alpha/beta 8.89 Evidence
WAS LILRB1 N/A 8.81 Evidence
WAS DNM2 N/A 8.40 Evidence
WAS YWHAQ YWHAQ: 14-3-3 protein theta 8.37 Evidence
WAS GLG1 GLG1: Golgi apparatus protein 1 8.24 Evidence
WAS KDR KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor 7.66 Evidence
WAS PTPN1 PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 7.45 Evidence
WAS GAB1 GAB1: GRB2-associated-binding protein 1 7.43 Evidence
WAS IRS4 IRS4, RP6-24A23.4-001, hCG_20762: Insulin receptor substrate 4 7.43 Evidence
WAS PRKDC PRKDC, HYRC, HYRC1: DNA-dependent protein kinase catalytic subunit 7.39 Evidence
WAS DNM1 DNM1, DNM: Dynamin-1 7.14 Evidence
WAS NMT1 NMT1, NMT: Glycylpeptide N-tetradecanoyltransferase 1 7.10 Evidence
WAS RPS3 RPS3, OK/SW-cl.26: 40S ribosomal protein S3 7.10 Evidence
WAS NFKBIA NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha 7.10 Evidence
WAS EPHB2 EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor 6.91 Evidence
WAS EPHB1 EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor 6.91 Evidence
WAS FYN FYN: Proto-oncogene tyrosine-protein kinase Fyn 6.82 Evidence O
WAS DAB2 DAB2, DOC2: Disabled homolog 2 6.81 Evidence
WAS ACTN4 ACTN4: Alpha-actinin-4 6.80 Evidence
WAS CD3E CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor 6.78 Evidence
WAS PLD2 PLD2: Phospholipase D2 6.66 Evidence
WAS MET MET: Hepatocyte growth factor receptor precursor 6.62 Evidence
WAS MERTK MERTK, MER: Proto-oncogene tyrosine-protein kinase MER precursor 6.62 Evidence
WAS TEK TEK, TIE2: Angiopoietin-1 receptor precursor 6.62 Evidence
WAS CCT4 CCT4, CCTD, SRB: T-complex protein 1 subunit delta 6.62 Evidence
WAS EGF EGF: Pro-epidermal growth factor precursor 6.52 Evidence
WAS ARPC1B ARC41, ARPC1B: Actin-related protein 2/3 complex subunit 1B 6.49 Evidence O
WAS VAV2 VAV2, RP11-153P4.1-003: Vav 2 oncogene 6.40 Evidence
WAS BCAR1 BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 6.39 Evidence
WAS CDC42BPA CDC42BPA: Serine/threonine-protein kinase MRCK alpha 6.14 Evidence
WAS NACA NACA, HSD48: Nascent polypeptide-associated complex subunit alpha 6.01 Evidence
WAS SMAD2 SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 6.01 Evidence
WAS HDAC1 HDAC1, RPD3L1: Histone deacetylase 1 6.01 Evidence
WAS IQGAP2 IQGAP2: Ras GTPase-activating-like protein IQGAP2 6.01 Evidence
WAS CAPZB 5.94 Evidence
WAS MST1R MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor 5.93 Evidence
WAS EPHB3 EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor 5.93 Evidence
WAS SH2D1A SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A 5.92 Evidence
WAS S100A3 S100A3, S100E: Protein S100-A3 5.90 Evidence
WAS TRAF2 TRAF2, TRAP3: TNF receptor-associated factor 2 5.9 Evidence
WAS STIP1 STIP1: Stress-induced-phosphoprotein 1 5.9 Evidence
WAS ITGB4 N/A 5.88 Evidence
WAS CBLC CBLC, CBL3, RNF57: Signal transduction protein CBL-C 5.88 Evidence
WAS SYTL4 Endocrine transmitter regulatory protein 5.87 Evidence
WAS TRPV4 TRPV4, VRL2, VROAC: Transient receptor potential cation channel subfamily V memb 5.87 Evidence
WAS IL6ST IL6ST: Interleukin-6 receptor subunit beta precursor 5.87 Evidence
WAS MYL4 MYL4, MLC1, PRO1957: Myosin light polypeptide 4 5.86 Evidence
WAS S100A4 S100A4, CAPL, MTS1: Protein S100-A4 5.85 Evidence
WAS EPHA2 EPHA2, ECK: Ephrin type-A receptor 2 precursor 5.84 Evidence
WAS IGF1R IGF1R: Insulin-like growth factor 1 receptor precursor 5.84 Evidence
WAS SOS2 SOS2: Son of sevenless homolog 2 5.64 Evidence
WAS EVL N/A 5.55 Evidence
WAS TNK2 TNK2, ACK1: Activated CDC42 kinase 1 5.50 Evidence
WAS IGFBP5 IGFBP5, IBP5: Insulin-like growth factor-binding protein 5 precursor 5.48 Evidence
WAS CHST7 CHST7: Carbohydrate sulfotransferase 7 5.45 Evidence
WAS DDX41 DDX41, ABS: Probable ATP-dependent RNA helicase DDX41 5.45 Evidence
WAS FCGR2A FCGR2A: Fc of IgG, low affinity IIa, receptor 5.32 Evidence
WAS HLA-DMA DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP 5.32 Evidence
WAS PRKCH PRKCH, PKCL, PRKCL: Protein kinase C eta type 5.30 Evidence
WAS CLK3 CLK3: Dual specificity protein kinase CLK3 5.30 Evidence
WAS DAB1 DAB1: Disabled homolog 1 5.29 Evidence
WAS CKAP1 TBCB, CG22, CKAP1: Tubulin folding cofactor B 5.28 Evidence
WAS EPHA4 EPHA4, HEK8, SEK, TYRO1: Ephrin type-A receptor 4 precursor 5.27 Evidence
WAS ERBB2 ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor 5.27 Evidence
WAS ADAM33 ADAM33, UNQ873/PRO1891: ADAM 33 precursor 5.26 Evidence
WAS CD22 CD22, SIGLEC2: B-cell receptor CD22 precursor 5.17 Evidence
WAS IFNAR1 IFNAR1, IFNAR: Interferon-alpha/beta receptor alpha chain precursor 5.17 Evidence
WAS MAG MAG, GMA: Myelin-associated glycoprotein precursor 5.17 Evidence
WAS ARPC4 ARPC4, ARC20: Actin-related protein 2/3 complex subunit 4 4.87 Evidence
WAS ZNF217 ZNF217, ZABC1: Zinc finger protein 217 4.77 Evidence
WAS GRB10 N/A 4.68 Evidence
WAS LIG1 LIG1: DNA ligase 1 4.63 Evidence
WAS RAB11FIP5 RAB11FIP5, GAF1, KIAA0857, RIP11: Rab11 family-interacting protein 5 4.54 Evidence
WAS SNTA1 SNTA1, SNT1: Alpha-1-syntrophin 4.54 Evidence
WAS IRS1 IRS1: Insulin receptor substrate 1 4.50 Evidence
WAS S100B S100B: Protein S100-B 4.50 Evidence
WAS LAT LAT: Linker for activation of T-cells family member 1 4.48 Evidence
WAS FABP4 FABP4: Fatty acid-binding protein, adipocyte 4.47 Evidence
WAS CAP1 CAP1, CAP: Adenylyl cyclase-associated protein 1 4.36 Evidence
WAS ARPC5 ARPC5, ARC16: Actin-related protein 2/3 complex subunit 5 4.36 Evidence
WAS TRIB2 TRIB2, TRB2: Tribbles homolog 2 4.34 Evidence
WAS SH3BP5 N/A 4.23 Evidence
WAS FXR1 FXR1: Fragile X mental retardation syndrome-related protein 1 4.23 Evidence
WAS STAT6 STAT6: Signal transducer and activator of transcription 6 4.23 Evidence
WAS FLT4 VEGFR3 long form 4.19 Evidence
WAS CD58 CD58, LFA3: Lymphocyte function-associated antigen 3 precursor 4.06 Evidence
WAS PIGR PIGR: Polymeric-immunoglobulin receptor precursor 4.04 Evidence
WAS SORBS3 SORBS3, SCAM1: Vinexin 4.04 Evidence
WAS YES1 YES1, YES: Proto-oncogene tyrosine-protein kinase Yes 4.04 Evidence
WAS TNIK TNIK, KIAA0551: TRAF2 and NCK-interacting protein kinase 4.04 Evidence
WAS FABP3 FABP3, FABP11, MDGI: Fatty acid-binding protein, heart 4.03 Evidence
WAS PTPRF PTPRF, LAR: Receptor-type tyrosine-protein phosphatase F precursor 4.01 Evidence
WAS CETN1 CETN1, CEN1, CETN: Centrin-1 4.01 Evidence
WAS PTPRC PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ 4.01 Evidence
WAS CNTN1 CNTN1: Contactin-1 precursor 4.01 Evidence
WAS TRPM7 TRPM7, CHAK1, LTRPC7: Transient receptor potential cation channel subfamily M me 4.01 Evidence
WAS EPOR EPOR: Erythropoietin receptor precursor 3.86 Evidence
WAS HSP90AB1 HSP90AB1, HSP90B, HSPC2, HSPCB: Heat shock protein HSP 90-beta 3.85 Evidence
WAS SIRT1 SIRT1, SIR2L1: NAD-dependent deacetylase sirtuin-1 3.85 Evidence
WAS PHF10 N/A 3.85 Evidence
WAS LSP1 3.81 Evidence
WAS SRMS SRMS, C20orf148: Tyrosine-protein kinase Srms 3.70 Evidence
WAS BIN3 BIN3: Bridging integrator 3 3.68 Evidence
WAS PTPRR PTPRR, ECPTP, PTPRQ: Receptor-type tyrosine-protein phosphatase R precursor 3.64 Evidence
WAS ADRB2 ADRB2, ADRB2R, B2AR: Beta-2 adrenergic receptor 3.64 Evidence
WAS CPNE1 RBM12, KIAA0765, HRIHFB2091: RNA-binding protein 12 3.47 Evidence
WAS ACP1 ACP1: Low molecular weight phosphotyrosine protein phosphatase 3.47 Evidence
WAS DCC DCC: Netrin receptor DCC precursor 3.46 Evidence
WAS PTPN11 N/A 3.45 Evidence
WAS PDLIM5 PDLIM5, ENH: PDZ and LIM domain protein 5 3.39 Evidence
WAS GHR GHR: Growth hormone receptor precursor 3.34 Evidence
WAS KRT6E KRT6C, KRT6E: Keratin, type II cytoskeletal 6C 3.34 Evidence
WAS SLC9A3R2 SLC9A3R2: SLC9A3R2 protein (Fragment) 3.34 Evidence
WAS SSRP1 SSRP1, FACT80: FACT complex subunit SSRP1 3.30 Evidence
WAS PTPRE PTPRE: Receptor-type tyrosine-protein phosphatase epsilon precursor 3.26 Evidence
WAS BRDG1 STAP1, BRDG1: Signal-transducing adaptor protein 1 3.18 Evidence
WAS IL10RB IL10RB, CRFB4, D21S58, D21S66: Interleukin-10 receptor beta chain precursor 3.18 Evidence
WAS GTF3C1 N/A 3.17 Evidence
WAS BRCA2 BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein 3.07 Evidence
WAS ESPL1 N/A 3.07 Evidence
WAS IL6R IL6R: Interleukin-6 receptor alpha chain precursor 3.07 Evidence
WAS WRNIP1 WRNIP1, WHIP: ATPase WRNIP1 2.99 Evidence
WAS BCR N/A 2.99 Evidence
WAS RAC1 N/A 2.99 Evidence
WAS PECAM1 PECAM1: Platelet endothelial cell adhesion molecule precursor 2.99 Evidence
WAS HDAC3 HDAC3: Histone deacetylase 3 2.93 Evidence
WAS SEC31L1 N/A 2.84 Evidence
WAS FRS3 FRS3: Fibroblast growth factor receptor substrate 3 2.80 Evidence
WAS SNX1 SNX1: Sorting nexin-1 2.79 Evidence
WAS GMFB GMFB: Glia maturation factor beta 2.75 Evidence
WAS SHC1 SHC1, RP11-307C12.1-001, hCG_1997126: SHC 2.75 Evidence
WAS NCAM1 NCAM1, NCAM: Neural cell adhesion molecule 1, 140 kDa isoform precursor 2.65 Evidence
WAS CD2BP2 CD2BP2, KIAA1178: CD2 antigen cytoplasmic tail-binding protein 2 2.64 Evidence
WAS CTNNB1 CTNNB1, CTNNB, OK/SW-cl.35, PRO2286: Catenin beta-1 2.63 Evidence
WAS CTPS CTPS: CTP synthase 1 2.63 Evidence
WAS CASP3 CASP3, CPP32: Caspase-3 precursor 2.63 Evidence
WAS MAP4K5 MAP4K5: Mitogen-activated protein kinase kinase kinase kinase 5 2.63 Evidence
WAS TNF TNF, TNFA, TNFSF2: Tumor necrosis factor precursor 2.6 Evidence
WAS GPRASP2 GPRASP2: G-protein coupled receptor-associated sorting protein 2 2.54 Evidence
WAS PKP4 PKP4: Plakophilin-4 2.54 Evidence
WAS SLC25A6 SLC25A6, ANT3, CDABP0051: ADP/ATP translocase 3 2.44 Evidence
WAS ANKK1 ANKK1, PKK2, SGK288: Ankyrin repeat and protein kinase domain-containing protein 2.43 Evidence
WAS THY1 THY1: Thy-1 membrane glycoprotein precursor 2.37 Evidence
WAS SLAMF1 SLAMF1, SLAM: Signaling lymphocytic activation molecule precursor 2.29 Evidence
WAS FXR2 FXR2, FMR1L2: Fragile X mental retardation syndrome-related protein 2 2.28 Evidence
WAS DCP1B DCP1B: mRNA-decapping enzyme 1B 2.28 Evidence
WAS PDE8B PDE8B: High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodies 2.28 Evidence
WAS DCTN1 DCTN1: Dynactin subunit 1 2.28 Evidence
WAS SVIL SVIL: Supervillin 2.28 Evidence
WAS UBE1L UBE1L: Ubiquitin-activating enzyme E1-like 2.28 Evidence
WAS CLTC CLTC, CLH17, CLTCL2, KIAA0034: Clathrin heavy chain 1 2.19 Evidence
WAS TUBA1 TUBA4A, TUBA1: Tubulin alpha-4A chain 2.17 Evidence
WAS PABPC4 PABPC4, APP1, PABP4: Polyadenylate-binding protein 4 2.17 Evidence
WAS ARHGDIB ARHGDIB, GDIA2, GDID4, RAP1GN1: Rho GDP-dissociation inhibitor 2 2.13 Evidence
WAS VAV2 VAV2: Uncharacterized protein VAV2 2.12 Evidence
WAS PPP3R1 PPP3R1, CNA2, CNB: Calcineurin subunit B isoform 1 2.11 Evidence
WAS MTHFD1 MTHFD1, MTHFC, MTHFD: C-1-tetrahydrofolate synthase, cytoplasmic 2.10 Evidence
WAS HDAC2 HDAC2: Histone deacetylase 2 2.05 Evidence
WAS WIRE WIPF2, WICH, PP10631, WIRE: WAS/WASL-interacting protein family member 2 2.04 Evidence
WAS VAV3 VAV3: Protein vav-3 2.04 Evidence
WAS SOCS1 SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 2.00 Evidence
WAS MS4A1 MS4A1, CD20: B-lymphocyte antigen CD20 1.98 Evidence
WAS CD79A CD79A, IGA, MB1: B-cell antigen receptor complex-associated protein alpha-chain 1.98 Evidence
WAS SHC3 SHC3, NSHC, SHCC: SHC-transforming protein 3 1.90 Evidence
WAS GRIN2A GRIN2A, NMDAR2A: Glutamate [NMDA] receptor subunit epsilon-1 precursor 1.83 Evidence
WAS SYN1 SYN1: Synapsin-1 1.79 Evidence
WAS CD36 CD36, GP3B, GP4: Platelet glycoprotein 4 1.77 Evidence
WAS LSM2 LSM2, C6orf28, G7b: U6 snRNA-associated Sm-like protein LSm2 1.77 Evidence
WAS DDR1 DDR1, CAK, EDDR1, NEP, NTRK4, PTK3A, RTK6, TRKE: Epithelial discoidin domain-con 1.71 Evidence
WAS PLAUR PLAUR, MO3, UPAR: Urokinase plasminogen activator surface receptor precursor 1.71 Evidence
WAS FCGR2B FCGR2B, CD32, FCG2, IGFR2: Low affinity immunoglobulin gamma Fc region receptor 1.71 Evidence
WAS APC N/A 1.70 Evidence
WAS SIPA1L1 SIPA1L1, E6TP1, KIAA0440: Signal-induced proliferation-associated 1-like protein 1.70 Evidence
WAS KIAA0664 KIAA0664: Putative eukaryotic translation initiation factor 3 subunit 1.70 Evidence
WAS STYK1 STYK1, NOK: Tyrosine protein-kinase STYK1 1.64 Evidence
WAS GRIN2B GRIN2B, NMDAR2B: Glutamate [NMDA] receptor subunit epsilon-2 precursor 1.63 Evidence
WAS CDC37 CDC37: Hsp90 co-chaperone Cdc37 1.62 Evidence
WAS FASLG FASLG, APT1LG1, FASL, TNFSF6: Tumor necrosis factor ligand superfamily member 6 1.57 Evidence
WAS RHOA RHOA, ARH12, ARHA, RHO12: Transforming protein RhoA precursor 1.57 Evidence
WAS PSTPIP1 PSTPIP1, CD2BP1: Proline-serine-threonine phosphatase-interacting protein 1 1.57 Evidence
WAS SLA SLA, SLAP, SLAP1: SRC-like-adapter 1.57 Evidence
WAS PIK3CD PIK3CD: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta i 1.57 Evidence
WAS FCGR1A FCGR1A, FCG1, FCGR1, IGFR1: High affinity immunoglobulin gamma Fc receptor I pre 1.55 Evidence
WAS H2-ALPHA TUBA3C, TUBA2, TUBA3D: Tubulin alpha-3C/D chain 1.53 Evidence
WAS DNM1 N/A 1.52 Evidence
WAS CTNND2 CTNND2, NPRAP: Catenin delta-2 1.52 Evidence
WAS CSNK2B CSNK2B, CK2N, G5A: Casein kinase II subunit beta 1.52 Evidence
WAS ANXA2 ANXA2, ANX2, ANX2L4, CAL1H, LPC2D: Annexin A2 1.50 Evidence
WAS CD3D CD3D, T3D: T-cell surface glycoprotein CD3 delta chain precursor 1.50 Evidence
WAS JUP JUP, CTNNG, DP3: Junction plakoglobin 1.5 Evidence
WAS IL2RG IL2RG: Cytokine receptor common gamma chain precursor 1.46 Evidence
WAS GRB7 GRB7: Growth factor receptor-bound protein 7 1.44 Evidence
WAS MAP2K7 MAP2K7, JNKK2, MEK7, MKK7, PRKMK7: Dual specificity mitogen-activated protein ki 1.44 Evidence
WAS RAC2 RAC2: Ras-related C3 botulinum toxin substrate 2 precursor 1.42 Evidence
WAS STK38 STK38, NDR1: Serine/threonine-protein kinase 38 1.41 Evidence
WAS STK10 STK10: Uncharacterized protein STK10 1.41 Evidence
WAS CXorf9 N/A 1.41 Evidence
WAS AHNAK AHNAK nucleoprotein isoform 1 1.38 Evidence
WAS CD79B CD79B, B29, IGB: B-cell antigen receptor complex-associated protein beta-chain p 1.30 Evidence
WAS TCF20 TCF20, KIAA0292, SPBP: Transcription factor 20 1.30 Evidence
WAS CD247 CD247, CD3Z, T3Z, TCRZ: T-cell surface glycoprotein CD3 zeta chain precursor 1.30 Evidence
WAS KCNJ3 KCNJ3, GIRK1: G protein-activated inward rectifier potassium channel 1 1.27 Evidence
WAS CNN3 CNN3: Calponin-3 1.21 Evidence
WAS CD5 CD5, LEU1: T-cell surface glycoprotein CD5 precursor 1.20 Evidence
WAS CD28 CD28: T-cell-specific surface glycoprotein CD28 precursor 1.20 Evidence
WAS TRERF1 TRERF1, BCAR2, RAPA, TREP132: Transcriptional-regulating factor 1 1.16 Evidence
WAS HSPA8 HSPA8, HSC70, HSP73, HSPA10: Heat shock cognate 71 kDa protein 1.15 Evidence
WAS CFL2 CFL2: Cofilin-2 1.15 Evidence
WAS EPN2 N/A 1.15 Evidence
WAS SASH1 SASH1, KIAA0790, PEPE1: SAM and SH3 domain-containing protein 1 1.15 Evidence
WAS CD1A CD1A: T-cell surface glycoprotein CD1a precursor 1.12 Evidence
WAS SIGLEC5 SIGLEC5, CD33L2, OBBP2: Sialic acid-binding Ig-like lectin 5 precursor 1.09 Evidence
WAS K-ALPHA-1 TUBA1B: Tubulin alpha-1B chain 1.07 Evidence
WAS CAV1 CAV1, CAV: Caveolin-1 1.06 Evidence
WAS ICAM3 ICAM3: Intercellular adhesion molecule 3 precursor 1.03 Evidence
WAS PIP3-E N/A 1.01 Evidence
WAS TOM1L1 TOM1L1, SRCASM: TOM1-like protein 1 1.01 Evidence
WAS TYRO3 TYRO3, BYK, DTK, RSE, SKY: Tyrosine-protein kinase receptor TYRO3 precursor 1.01 Evidence
WAS TSHR N/A 1.00 Evidence